Immediate Impact
2 from Science/Nature 52 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy
2025 Standout
Works of Ke Zhou being referenced
RapaLink-1 outperforms rapamycin in alleviating allogeneic graft rejection by inhibiting the mTORC1-4E-BP1 pathway in mice
2023
Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour‐associated fibroblast
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ke Zhou | 196 | 83 | 150 | 41 | 432 | |
| Liangdan Tang | 213 | 58 | 88 | 34 | 504 | |
| Yaping Yuan | 208 | 72 | 109 | 35 | 505 | |
| Hélio Humberto Angotti Carrara | 151 | 171 | 106 | 50 | 511 | |
| Qing Yuan | 155 | 52 | 90 | 38 | 377 | |
| Qingjian Li | 220 | 46 | 161 | 35 | 472 | |
| Deguang Kong | 211 | 143 | 120 | 24 | 459 | |
| Xiaojian Ni | 252 | 193 | 179 | 31 | 456 | |
| Yonggang He | 223 | 129 | 153 | 44 | 485 | |
| Ying Deng | 132 | 69 | 101 | 54 | 428 | |
| Raquel Andrés | 160 | 151 | 145 | 30 | 437 |
All Works
Login with ORCID to disown or claim papers
Loading papers...